LCAP (Long Covid Action Project)
Media Contact: Joshua Pribanic
Phone number: 419-202-8503
Email: joshua@publicheraldstudios.com
Long COVID Foundation (LCF)
Phone Number: 631-296-2221
Media Contact: Devin Russell (LCF)
Email: info@longcfoundation.org
FOR IMMEDIATE RELEASE: 9/05/24
Grassroots Activists Help Fund Study To Validate A Long COVID Blood Test
LCAP & the Long COVID Foundation are thrilled to announce the funding goal set by Dr. Johan Van Weyenbergh, and his research team, for Long COVID Biomarkers Validation has been reached. This was accomplished thanks to the incredible support of more than 200 donors, plus separate funding provided directly to Dr. Van Weyenbergh from the Polybio Research Foundation. We see this as a historic grassroots effort giving researchers an opportunity to validate a Long COVID blood test.
We are pleased to say that the payment of $34,111.75 has been sent to immunologist Dr. Johan Van Weyenbergh at the Rega Institute for Medical Research and his team to work on their transcriptomic study validating testing of Long COVID biomarkers.
“We are elated with the response of the Long COVID community to this vital Long COVID biomarker fundraising campaign,” said Devin Russell of the Long COVID Foundation. “Long Haulers understand the importance of having tests for Long COVID and SARS-CoV-2 viral persistence. We can’t expect good treatments for those suffering with Long COVID until we have good diagnostics, which is something those with HIV lived as well.”
”I’m extremely grateful to LCAP, LCF, PolyBio Foundation and the grassroots community for this vital support to our blood test research on Long COVID biomarkers,” says Dr. Johan Van Weyenbergh. “This funding will allow us to start work on validating the blood biomarkers we previously discovered, by replicating these findings in a new international patient cohort.”
“LCAP asks the NIH director Monica M. Bertagnolli, M.D. to take notice of this vital research and quickly adapt the transcriptomic blood test throughout the RECOVER program to begin measuring SARS-CoV-2 viral load,” said LCAP founder Joshua Pribanic. “The time for action for hundreds of millions of people worldwide, for tens of millions of children who have no Long COVID biomarkers in clinical settings, is now.”
Raising more than $34,000 in a few short weeks, and PolyBio seeing the merit for this science donating funds via their own efforts for this test validation, highlights how important it is to have a blood test and biomarkers for Long COVID. It also shows that this transcriptomic test is one worthy of further study.
We are hopeful that the money raised will be a major turning point in developing a blood test for Long COVID diagnostics and new treatments for those suffering with Long COVID. Thank you everyone for your hard work on this campaign. We will keep you updated on the progress.
